Literature DB >> 19603102

Regulatory NK-cell functions in inflammation and autoimmunity.

Anna Lünemann1, Jan D Lünemann, Christian Münz.   

Abstract

Natural killer (NK) cells were viewed traditionally as cytotoxic effector cells whose rapid killing of infected and transformed cells without preactivation provides a first line of defense prior to the initiation of an adaptive immune response against infection and tumor development. However, it has become clear that NK cells interact with various components of the immune system, and therefore have the potential to function as regulatory cells. While NK cells can assist in dendritic cell (DC) maturation and T-cell polarization, increasing evidence indicates that NK cells can also prevent and limit adaptive (auto) immune responses via killing of autologous myeloid and lymphoid cells. Investigating immunoregulatory NK-cell functions might generate exciting insights into the reciprocal regulation between NK-cell-mediated innate immunity and adaptive immune responses, improve our capacity to monitor these cells as surrogate markers for disease activity and treatment responses in autoimmune diseases, and, perhaps, provide new prospects for NK cell-directed therapies.

Entities:  

Mesh:

Year:  2009        PMID: 19603102      PMCID: PMC2710290          DOI: 10.2119/molmed.2009.00035

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  90 in total

1.  The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.

Authors:  DeRen Huang; Fu-Dong Shi; Steffen Jung; Gary C Pien; Jintang Wang; Thais P Salazar-Mather; Toby T He; Jennifer T Weaver; Hans-Gustaf Ljunggren; Christine A Biron; Dan R Littman; Richard M Ransohoff
Journal:  FASEB J       Date:  2006-05       Impact factor: 5.191

Review 2.  CD4+CD25+ Tregs and NKT cells: regulators regulating regulators.

Authors:  Antonio La Cava; Luc Van Kaer
Journal:  Trends Immunol       Date:  2006-06-02       Impact factor: 16.687

Review 3.  Immunoregulation of autoimmunity by natural killer T cells.

Authors:  Loes Linsen; Veerle Somers; Piet Stinissen
Journal:  Hum Immunol       Date:  2006-03-31       Impact factor: 2.850

4.  Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

Authors:  Linrong Lu; Koichi Ikizawa; Dan Hu; Miriam B F Werneck; Kai W Wucherpfennig; Harvey Cantor
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

5.  NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice.

Authors:  Rongbin Zhou; Haiming Wei; Zhigang Tian
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

6.  NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion.

Authors:  Barbara Morandi; Gwenola Bougras; William A Muller; Guido Ferlazzo; Christian Münz
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

7.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15.

Authors:  Mathias Lucas; William Schachterle; Karin Oberle; Peter Aichele; Andreas Diefenbach
Journal:  Immunity       Date:  2007-03-29       Impact factor: 31.745

8.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Authors:  Thierry Walzer; Mathieu Bléry; Julie Chaix; Nicolas Fuseri; Lionel Chasson; Scott H Robbins; Sébastien Jaeger; Pascale André; Laurent Gauthier; Laurent Daniel; Karine Chemin; Yannis Morel; Marc Dalod; Jean Imbert; Michel Pierres; Alessandro Moretta; François Romagné; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

9.  Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta.

Authors:  M Saraste; H Irjala; L Airas
Journal:  Neurol Sci       Date:  2007-06-30       Impact factor: 3.307

10.  Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.

Authors:  Shlomo Nedvetzki; Stefanie Sowinski; Robert A Eagle; James Harris; Frédéric Vély; Daniela Pende; John Trowsdale; Eric Vivier; Siamon Gordon; Daniel M Davis
Journal:  Blood       Date:  2007-01-11       Impact factor: 22.113

View more
  50 in total

1.  Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.

Authors:  Hye J Kim; Jong S Lee; Jung D Kim; Hee J Cha; Ahra Kim; Sun K Lee; Sang C Lee; Byoung S Kwon; Robert S Mittler; Hong R Cho; Byungsuk Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Adaptive immune responses mediated by natural killer cells.

Authors:  Silke Paust; Balimkiz Senman; Ulrich H von Andrian
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 3.  Immune-mediated processes in neurodegeneration: where do we stand?

Authors:  Marc Fakhoury
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

Review 4.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

5.  Low-dose IL-2 induces CD56bright NK regulation of T cells via NKp44 and NKp46.

Authors:  S T Loughran; P A Power; S L McQuaid; P Maguire; A Szczygiel; P A Johnson
Journal:  Clin Exp Immunol       Date:  2020-02-13       Impact factor: 4.330

Review 6.  Natural killer cell memory.

Authors:  Silke Paust; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

7.  Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.

Authors:  Ren Zhu; Maryline Mancini-Bourgine; Xiao Ming Zhang; Florence Bayard; Qiang Deng; Marie-Louise Michel
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

8.  Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study.

Authors:  Di Wu; Peng Wang; Meifang Han; Yongping Chen; Xinyue Chen; Qi Xia; Weiming Yan; Xiaoyang Wan; Chuanlong Zhu; Qing Xie; Jiaji Jiang; Lai Wei; Deming Tan; Xiaoguang Dou; Yanyan Yu; Jinlin Hou; Xiaoping Luo; Qin Ning
Journal:  Hepatol Int       Date:  2019-06-06       Impact factor: 6.047

9.  Report on the 1st scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Mittenwalde/Motzen, Germany, Oct. 30th - Nov. 1st, 2009.

Authors:  Tim Magnus; Ralf Linker; Sven G Meuth; Christoph Kleinschnitz; Thomas Korn
Journal:  Exp Transl Stroke Med       Date:  2010-03-31

10.  Acute clearance of human metapneumovirus occurs independently of natural killer cells.

Authors:  Sherry C Wen; Sharon J Tollefson; Monika Johnson; Pavlo Gilchuk; Kelli L Boyd; Bryan Shepherd; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.